142 related articles for article (PubMed ID: 36099441)
1. Validation of BD Onclarity HPV Assay on Vaginal Self-Samples versus Cervical Samples Using the VALHUDES Protocol.
Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Donders G; Doyen J; Tjalma W; De Sutter P; Peeters E; Vorsters A; Arbyn M
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2177-2184. PubMed ID: 36099441
[TBL] [Abstract][Full Text] [Related]
2. Clinical Performance of the RealTi
Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Tjalma WAA; Doyen J; Donders G; De Sutter P; Vorsters A; Peeters E; Arbyn M
Microbiol Spectr; 2022 Oct; 10(5):e0163122. PubMed ID: 36047900
[TBL] [Abstract][Full Text] [Related]
3. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework.
Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Donders G; Doyen J; Tjalma W; De Sutter P; Vorsters A; Arbyn M
J Mol Diagn; 2023 Sep; 25(9):702-708. PubMed ID: 37354994
[TBL] [Abstract][Full Text] [Related]
5. Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples.
Martinelli M; Latsuzbaia A; Bonde J; Pedersen H; Iacobone AD; Bottari F; Piana AF; Pietri R; Cocuzza CE; Arbyn M;
Microbiol Spectr; 2024 Mar; 12(3):e0287223. PubMed ID: 38323823
[TBL] [Abstract][Full Text] [Related]
6. Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study.
Van Keer S; Latsuzbaia A; Vanden Broeck D; De Sutter P; Donders G; Doyen J; Tjalma WAA; Weyers S; Arbyn M; Vorsters A
J Clin Virol; 2022 Oct; 155():105271. PubMed ID: 36049283
[TBL] [Abstract][Full Text] [Related]
7. Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol.
Latsuzbaia A; Van Keer S; Vanden Broeck D; Weyers S; Donders G; De Sutter P; Tjalma W; Doyen J; Vorsters A; Arbyn M
J Mol Diagn; 2023 Dec; 25(12):957-966. PubMed ID: 37865293
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections.
Jentschke M; Chen K; Arbyn M; Hertel B; Noskowicz M; Soergel P; Hillemanns P
J Clin Virol; 2016 Sep; 82():46-50. PubMed ID: 27434147
[TBL] [Abstract][Full Text] [Related]
9. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
Bokan T; Ivanus U; Jerman T; Takac I; Arko D
Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1.
Cadman L; Reuter C; Jitlal M; Kleeman M; Austin J; Hollingworth T; Parberry AL; Ashdown-Barr L; Patel D; Nedjai B; Lorincz AT; Cuzick J
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):661-668. PubMed ID: 33514604
[TBL] [Abstract][Full Text] [Related]
11. Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay?
Solnæs JV; Njor SH; Tranberg M
BMC Womens Health; 2023 Feb; 23(1):78. PubMed ID: 36823528
[TBL] [Abstract][Full Text] [Related]
12. Performance of a six-methylation-marker assay on self-collected cervical samples - A feasibility study.
Klischke L; von Ehr J; Kohls F; Kampers J; Hülse F; Schmitz M; Hennig A; Dörk T; Hillemanns P; Jentschke M
J Virol Methods; 2021 Sep; 295():114219. PubMed ID: 34175345
[TBL] [Abstract][Full Text] [Related]
13. Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
Van Keer S; Peeters E; Vanden Broeck D; De Sutter P; Donders G; Doyen J; Tjalma WAA; Weyers S; Vorsters A; Arbyn M
Gynecol Oncol; 2021 Sep; 162(3):575-583. PubMed ID: 34172287
[TBL] [Abstract][Full Text] [Related]
14. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women referred for colposcopy. A cross-sectional study.
Ørnskov D; Jochumsen K; Steiner PH; Grunnet IM; Lykkebo AW; Waldstrøm M
BMJ Open; 2021 Mar; 11(3):e041512. PubMed ID: 33674367
[TBL] [Abstract][Full Text] [Related]
16. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.
Polman NJ; Ebisch RMF; Heideman DAM; Melchers WJG; Bekkers RLM; Molijn AC; Meijer CJLM; Quint WGV; Snijders PJF; Massuger LFAG; van Kemenade FJ; Berkhof J
Lancet Oncol; 2019 Feb; 20(2):229-238. PubMed ID: 30658933
[TBL] [Abstract][Full Text] [Related]
17. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
[TBL] [Abstract][Full Text] [Related]
18. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework.
Bonde JH; Pedersen H; Quint W; Xu L; Arbyn M; Ejegod DM
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723012
[TBL] [Abstract][Full Text] [Related]
20. Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.
Leinonen MK; Schee K; Jonassen CM; Lie AK; Nystrand CF; Rangberg A; Furre IE; Johansson MJ; Tropé A; Sjøborg KD; Castle PE; Nygård M
J Clin Virol; 2018; 99-100():22-30. PubMed ID: 29289814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
